Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 50.26%-1.72M | -221.38%-1.95M | -115.91%-4.26M | 36.49%-6.88M | 1.87%-835.76K | -102.08%-3.46M | 82.72%-606.48K | 58.49%-1.97M | 60.18%-10.83M | 86.54%-851.65K |
| Net income from continuing operations | -18.24%-4.75M | -191.31%-9.77M | -317.89%-8.74M | 18.18%-14.92M | -230.37%-5.46M | -254.96%-4.02M | 38.94%-3.35M | 79.00%-2.09M | 31.73%-18.23M | 73.14%-1.65M |
| Operating gains losses | 300.78%522.71K | 5,204.64%8.74M | 150.17%1.21M | 54.29%-2.53M | 46.18%-2.92M | -3,341.25%-260.34K | 150.18%164.68K | 133.89%484.04K | -1,990.05%-5.53M | -1,700.86%-5.42M |
| Depreciation and amortization | 20.30%145.34K | 3.34%141.38K | 7.95%129.69K | -80.43%490.57K | -7.70%112.8K | -17.71%120.81K | -87.65%136.81K | -89.37%120.14K | -44.73%2.51M | -89.41%122.22K |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --4.56M | --236.19K |
| Unrealized gains and losses of investment securities | ---782.88K | ---920.2K | --718.83K | -61.56%145.47K | 40.87%145.47K | --0 | --0 | --0 | 61.56%378.43K | 253.96%103.26K |
| Remuneration paid in stock | 1,422.67%996.19K | 661.79%849.58K | 404.43%291.27K | -96.03%152.21K | -182.99%-82.48K | -48.14%65.42K | -72.35%111.52K | -98.20%57.74K | 150.48%3.84M | -80.38%99.38K |
| Other non cashItems | 30.22%13.51K | 1,015.68%93.24K | 14,755.00%1.84M | -1.59%23.9K | -100.15%-7.24K | 100.52%10.37K | 100.29%8.36K | 423.14%12.41K | -40.46%24.29K | 4,719.31%4.94M |
| Change In working capital | 244.75%2.13M | -146.57%-1.08M | 151.09%284.21K | 495.72%9.76M | 926.00%7.37M | -46.04%618.21K | 1,126.30%2.32M | -245,168.28%-556.31K | 123.00%1.64M | 145.67%718.33K |
| -Change in receivables | 156.36%295.69K | -94.67%61.35K | -15.90%513.61K | 719.87%4.52M | 6,701.00%3.28M | -220.15%-524.65K | 232.14%1.15M | 349.13%610.74K | 89.90%-728.72K | 96.59%-49.7K |
| -Change in inventory | ---753 | --16.99K | --23.39K | ---117.24K | ---117.24K | --0 | --0 | --0 | --0 | ---- |
| -Change in prepaid assets | 2,179.95%413.93K | -316.50%-308.88K | 36.01%-75.31K | -72.73%86.38K | -57.87%81.29K | -112.90%-19.9K | -57.39%142.67K | 67.79%-117.68K | -60.21%316.72K | -66.98%192.95K |
| -Change in payables and accrued expense | 22.33%1.42M | -85.66%147.92K | 83.09%-177.48K | 108.33%4.27M | 443.46%3.13M | 109.60%1.16M | 233.69%1.03M | -271.81%-1.05M | 392.92%2.05M | --575.08K |
| -Change in other working capital | --0 | ---- | ---- | --1M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | 0 | 0 | ||||||||
| Operating cash flow | 50.26%-1.72M | -221.38%-1.95M | -115.91%-4.26M | 36.49%-6.88M | 1.87%-835.76K | -102.08%-3.46M | 82.72%-606.48K | 58.49%-1.97M | 61.79%-10.83M | 86.54%-851.65K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 111.79%408.42K | -284.41%-1.36M | -5,998.50%-1.35M | -457.74%-1.5M | 1.24M | -1,184.78%-3.46M | 738.22K | -22.14K | 55.63%-269.58K | 0 |
| Net PPE purchase and sale | ---- | --85.72K | --268.29K | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
| Net intangibles purchas and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Net business purchase and sale | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --31.78K | --0 |
| Net investment purchase and sale | 111.79%408.42K | -284.41%-1.36M | -5,998.50%-1.35M | -398.92%-1.5M | --1.24M | -1,049.28%-3.46M | --738.22K | ---22.14K | -23.72%-301.36K | --0 |
| Cash from discontinued investing activities | 0 | 0 | ||||||||
| Investing cash flow | 111.79%408.42K | -284.41%-1.36M | -5,998.50%-1.35M | -457.74%-1.5M | --1.24M | -1,184.78%-3.46M | --738.22K | ---22.14K | -102.22%-269.58K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -96.12%261.43K | -30.09%1.29M | 450.97%3.13M | 471.61%11.62M | 9,885.24%2.47M | 12,400.66%6.74M | 4,378.90%1.84M | 118.94%568.72K | -51.09%-3.13M | 49.10%-25.22K |
| Net issuance payments of debt | 186.18%264.92K | 147,699.16%1.93M | 1,033.97%3.09M | 601.58%948.25K | 3,989.26%982.08K | -461.21%-307.41K | 102.39%1.31K | 601.31%272.28K | -32.14%-189.05K | 49.03%-25.25K |
| Net common stock issuance | --0 | -99.98%439 | --0 | 460.76%10.67M | 4,368,917.65%1.49M | --7.05M | --1.84M | 110.02%296.44K | -53.55%-2.96M | --34 |
| Proceeds from stock option exercised by employees | --0 | --145.46K | --45.89K | --0 | --0 | --0 | --0 | --0 | --20.25K | --0 |
| Net other financing activities | ---3.5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -96.12%261.43K | -30.09%1.29M | 450.97%3.13M | 471.61%11.62M | 9,885.24%2.47M | 12,400.66%6.74M | 4,378.90%1.84M | 118.94%568.72K | -51.09%-3.13M | 49.10%-25.22K |
| Net cash flow | ||||||||||
| Beginning cash position | -54.71%1.5M | 164.49%3.52M | 117.47%6M | -83.76%2.76M | -14.14%3.12M | -41.69%3.31M | -85.58%1.33M | -83.76%2.76M | -51.84%16.98M | -84.70%3.63M |
| Current changes in cash | -464.13%-1.05M | -202.24%-2.02M | -73.64%-2.48M | 122.77%3.24M | 427.94%2.88M | 90.85%-186.42K | 155.64%1.98M | 81.61%-1.43M | 22.19%-14.22M | 87.04%-876.87K |
| End cash Position | -85.71%445.94K | -54.71%1.5M | 164.49%3.52M | 117.47%6M | 117.47%6M | -14.14%3.12M | -41.69%3.31M | -85.58%1.33M | -83.76%2.76M | -83.76%2.76M |
| Free cash from | 50.26%-1.72M | -221.38%-1.95M | -115.91%-4.26M | 36.49%-6.88M | 1.87%-835.76K | -102.08%-3.46M | 82.72%-606.48K | 58.49%-1.97M | 62.27%-10.83M | 86.53%-851.65K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.